Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeidelbergCapital is an independent venture capital and private equity firm based in Heidelberg, Germany, specializing in the life sciences and technology sectors. The firm manages the Heidelberg Innovation funds and provides growth capital, strategic guidance, and extensive industry networks to innovative European companies. Its investment focus primarily includes biotechnology, medical technology, diagnostics, and specialized healthcare services. HeidelbergCapital typically targets early-stage and growth-stage enterprises that possess strong intellectual property and the potential for significant market impact. The firm has played a pivotal role in the development of the Rhine-Neckar biotech cluster, supporting numerous successful startups from inception through to clinical milestones or exits. Notable portfolio companies have included oncology-focused biotechs and advanced diagnostic providers, reflecting the firm's deep expertise in complex therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeidelbergCapital.